is glp 1 safe for breast cancer survivors GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Sharing some research on GLP-1

Diana M, Raij T, Melis M, et al

Theoretical Concerns From Mechanism While NNMT inhibition is a promising research target, the mechanism raises points that warrant caution in interpretation

It has been clinically studied to help support GLP-1 levels and may support positive gut flora

Common NAD therapy protocols: Loading phase: 4 to 6 sessions over 2 to 4 weeks Dosage typically ranges from 250 mg to 1000 mg per session (IV or IM) Some protocols recommend two injections or infusions per week Maintenance phase: 1 session every 2 to 4 weeks Can extend to every 2 to 3 months for general wellness Adjusted based on results, energy levels, or lab feedback While NAD therapy isnt a one-size-fits-all treatment, most people start noticing benefits after just a few consistent sessions

Lister, C

Persistence on treatment was defined based on refilled prescription at follow-up visits